The University of Southampton
University of Southampton Institutional Repository

Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study

Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study
Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study
Early identification of patients at risk of failing first-line therapy remains a key challenge in primary mediastinal B-cell lymphoma (PMBCL). This study assessed whether positron emission tomography (PET) radiomics could predict treatment outcomes in PMBCL. Baseline PET/computed tomography (CT) scans from 501 patients enrolled in the International Extranodal Lymphoma Study Group 37 (IELSG37) trial and treated with rituximab- and doxorubicin-based immunochemotherapy were analysed. Functional PET parameters reflecting tumour burden (metabolic tumour volume, MTV), glucose consumption (total lesion glycolysis, TLG) and metabolic heterogeneity (MH) were calculated using a 25% maximum standard uptake value (SUVmax) segmentation threshold. Radiomic analysis was performed in 495 patients, extracting 107 features; 74 features uncorrelated with SUVmax and MTV were selected and analysed using a recursive-partitioning classification tree (Ctree) approach. Ctree identified grey-level run-length matrix run variance (GLRLM-RV), a marker of MH, as the most significant prognostic feature. Patients with low MH (GLRLM-RV <0.136) had a 5-year progression-free survival (PFS) of 93%, compared with 65% in those with high MH (p < 0.0001). Five-year overall survival (OS) was 96% vs. 80% respectively (p < 0.0001). A subsequent Ctree model integrating GLRLM-RV and TLG further improved prognostic stratification for PFS and OS (p < 0.0001), outperforming established prognostic indices (International Prognostic Index [IPI], revised-IPI and age-adjusted IPI).
0007-1048
393-856
Ceriani, Luca
5767bf0b-1df0-4479-90df-a3e0beb1c8b8
Milan, Lisa
d659fb5e-8d6c-41be-b1cc-b7114772f052
Cascione, Luciano
bda3280b-5e39-4604-9456-f684082bd3c0
Di Rocco, Alessandro
1fe48111-b6bf-4186-a450-4c07e55d9fcc
Kryachouk, Iryna
7edfb59a-b48e-48a2-86cd-89cd7e82f9f4
Davies, Andy J.
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Stathis, Anastasios
1c6ad6b5-a68c-4203-b576-8b846744b228
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Johnson, P.W.M.
26932758-e8d4-4676-9e55-ed36d00665ea
Martelli, Maurizio
32f72970-6db0-45ec-9246-6d074b504192
Zucca, Emanuele
40bd5950-d74e-4169-a2ea-0bfc1058058e
Ceriani, Luca
5767bf0b-1df0-4479-90df-a3e0beb1c8b8
Milan, Lisa
d659fb5e-8d6c-41be-b1cc-b7114772f052
Cascione, Luciano
bda3280b-5e39-4604-9456-f684082bd3c0
Di Rocco, Alessandro
1fe48111-b6bf-4186-a450-4c07e55d9fcc
Kryachouk, Iryna
7edfb59a-b48e-48a2-86cd-89cd7e82f9f4
Davies, Andy J.
0fe6a40a-10d1-4ade-a7e6-d1dceb2470af
Stathis, Anastasios
1c6ad6b5-a68c-4203-b576-8b846744b228
Rossi, Davide
b4b2506d-794c-4c79-8b2d-6767554fd52a
Johnson, P.W.M.
26932758-e8d4-4676-9e55-ed36d00665ea
Martelli, Maurizio
32f72970-6db0-45ec-9246-6d074b504192
Zucca, Emanuele
40bd5950-d74e-4169-a2ea-0bfc1058058e

Ceriani, Luca, Milan, Lisa, Cascione, Luciano, Di Rocco, Alessandro, Kryachouk, Iryna, Davies, Andy J., Stathis, Anastasios, Rossi, Davide, Johnson, P.W.M., Martelli, Maurizio and Zucca, Emanuele (2026) Metabolic heterogeneity-based radiomic model predicts treatment outcomes of primary mediastinal B-cell lymphoma patients in the IELSG37 study. British Journal of Haematology, 209 (2), 393-856. (doi:10.1111/bjh.70614).

Record type: Article

Abstract

Early identification of patients at risk of failing first-line therapy remains a key challenge in primary mediastinal B-cell lymphoma (PMBCL). This study assessed whether positron emission tomography (PET) radiomics could predict treatment outcomes in PMBCL. Baseline PET/computed tomography (CT) scans from 501 patients enrolled in the International Extranodal Lymphoma Study Group 37 (IELSG37) trial and treated with rituximab- and doxorubicin-based immunochemotherapy were analysed. Functional PET parameters reflecting tumour burden (metabolic tumour volume, MTV), glucose consumption (total lesion glycolysis, TLG) and metabolic heterogeneity (MH) were calculated using a 25% maximum standard uptake value (SUVmax) segmentation threshold. Radiomic analysis was performed in 495 patients, extracting 107 features; 74 features uncorrelated with SUVmax and MTV were selected and analysed using a recursive-partitioning classification tree (Ctree) approach. Ctree identified grey-level run-length matrix run variance (GLRLM-RV), a marker of MH, as the most significant prognostic feature. Patients with low MH (GLRLM-RV <0.136) had a 5-year progression-free survival (PFS) of 93%, compared with 65% in those with high MH (p < 0.0001). Five-year overall survival (OS) was 96% vs. 80% respectively (p < 0.0001). A subsequent Ctree model integrating GLRLM-RV and TLG further improved prognostic stratification for PFS and OS (p < 0.0001), outperforming established prognostic indices (International Prognostic Index [IPI], revised-IPI and age-adjusted IPI).

Text
Metabolic heterogeneity_accepted_May 2026 - Accepted Manuscript
Restricted to Repository staff only until 16 June 2027.
Available under License Creative Commons Attribution.
Request a copy

More information

Accepted/In Press date: 29 May 2026
e-pub ahead of print date: 16 June 2026
Published date: August 2026

Identifiers

Local EPrints ID: 514878
URI: https://eprints.soton.ac.uk/id/eprint/514878
ISSN: 0007-1048
PURE UUID: 170810ef-bf1e-4a9e-83e1-f1371db05c81
ORCID for Andy J. Davies: ORCID iD orcid.org/0000-0002-7517-6938

Catalogue record

Date deposited: 01 Oct 2026 17:04
Last modified: 02 Oct 2026 01:47

Export record

Altmetrics

Contributors

Author: Luca Ceriani
Author: Lisa Milan
Author: Luciano Cascione
Author: Alessandro Di Rocco
Author: Iryna Kryachouk
Author: Andy J. Davies ORCID iD
Author: Anastasios Stathis
Author: Davide Rossi
Author: P.W.M. Johnson
Author: Maurizio Martelli
Author: Emanuele Zucca

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×